Dr. Greg Garfield serves as Senior Managing Director & Head of the medical technologies division at KCK Group. He is a Board Member at Applaud Medical, Earlens, Intuity Medical, Sonitus Technologies, RefleXion Medical, C2 Therapeutics, Aerin MEdical, Rodo Medical, COgent Therapeutics, Semler Scientific, BioInspire Technologies, Vital COnnect and Sonitus Medical. Previously, he served as the COO at Acclarent. He served as Board Member at ReVent Medical. Prior to that, he was Vice President, New Business Development with Boston Scientific 's Cardiovascular Group. Prior to that, he spent 11 years in a variety of different roles within Guidant Corporation, including General Counsel of the Cardiac Surgery Group, Compass (Guidant's corporate investment group), and Guidant's affiliate in Japan. Prior to joining Guidant, Mr. Garfield spent a number of years in private practice representing start-up companies from Pillsbury Winthrop's Menlo Park office. He holds a BS degree in Agricultural Business Management from Cal Poly in San Luis Obispo, California, and a Juris Doctorate from the University of the Pacific, McGeorge School of Law. He also serves as a Board Member at Cerapedics .